Prosecution Insights
Last updated: April 19, 2026

Metriopharm AG

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18255262 LUMINOL FOR THE PROPHYLAXIS AND THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION NESTOR, DONNA MICHELLE 1627 Final Rejection May 31, 2023
18001034 COMPOUND FOR THE TREATMENT OF CORONAVIRAL INFECTIONS BAUER, NICOLA MARIA 1621 Non-Final OA Dec 07, 2022

Managing Metriopharm AG's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month